End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.03 USD | +0.75% | -1.47% | -7.78% |
Feb. 25 | Birzeit Pharmaceuticals Company Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 09 | What does the Gotham City report say about Grifols? | RE |
Financials (USD)
Sales 2022 | 47.03M | Sales 2023 | 43.13M | Capitalization | 169M |
---|---|---|---|---|---|
Net income 2022 | 7M | Net income 2023 | 6M | EV / Sales 2022 | 3.31 x |
Net cash position 2022 | 15.41M | Net cash position 2023 | 17.19M | EV / Sales 2023 | 3.53 x |
P/E ratio 2022 |
21.5
x | P/E ratio 2023 |
27.3
x | Employees | - |
Yield 2022 |
2.27% | Yield 2023 |
-
| Free-Float | 73.92% |
1 day | +0.75% | ||
1 week | -1.47% | ||
Current month | -3.59% | ||
1 month | -1.47% | ||
3 months | -4.95% | ||
6 months | +0.75% | ||
Current year | -7.78% |
Managers | Title | Age | Since |
---|---|---|---|
Talal Nasereddin
CEO | Chief Executive Officer | 74 | 84-03-31 |
Director of Finance/CFO | - | 84-11-14 | |
Chief Tech/Sci/R&D Officer | - | 97-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 20-12-31 | |
Chief Administrative Officer | 54 | 91-12-31 | |
Talal Nasereddin
CEO | Chief Executive Officer | 74 | 84-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 4.03 | +0.75% | 12,500 |
24-05-22 | 4 | -0.99% | 2,667 |
End-of-day quote Palestine Exchange, May 22, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-7.78% | 156M | |
+18.04% | 42.95B | |
+16.92% | 21.38B | |
+18.33% | 15.05B | |
+19.27% | 14.45B | |
+56.12% | 13.04B | |
-0.05% | 6.79B | |
-10.73% | 6.72B | |
-8.87% | 5.73B | |
+11.21% | 5.47B |
- Stock Market
- Equities
- BPC Stock